Endovascular treatment of chronic mesenteric ischemia is currently the treatment of choice, regardless of the number of involved vessels. Unlike other anatomic areas, the hyperperfusion produced by revascularization and the consecutive reperfusion syndrome is only described in cases of acute bowel ischemia, which is usually resolved with traditional surgery. We present a case of severe hyperperfusion syndrome secondary to endovascular correction with stents of a critical ischemia affecting the celiac trunk and superior mesenteric artery.
MisiakosEPTsapralisDKaratzasT. Advents in the diagnosis and management of ischemic colitis. Front Surg. 2017;4:47.
2.
SilvaJAWhiteCJCollinsTJ. Endovascular therapy for chronic mesenteric ischemia. JACC. 2006;47(5):944–950.
3.
TheodoropoulouAKoutroubakisIE. Ischemic colitis: clinical practice in diagnosis and treatment. World J Gastroenterol. 2008;14(48):7302–7308.
4.
GibbonsCPRobertsDE. Endovascular treatment of chronic arterial mesenteric ischemia: a changing perspective?Semin Vasc Surg. 2010;23(1):47–53.
5.
Rong KeSChiangFT. Endovascular therapy for a patient with chronic mesenteric ischemia. J Formos Med Assoc. 2010;109(4):315–319.
6.
AbuRahmaAFCampbellJEStonePA. Perioperative and late clinical outcomes of percutaneous transluminal stentings of the celiac and superior mesenteric arteries over the past decade. J Vasc Surg. 2013;57(4):1052–1061.
7.
JosephGAgarwalS. Successful endovascular treatment of severe chronic mesenteric ischemia by concurrent triple-vessel mesenteric artery revascularization. Indian Heart J. 2015;67(2):144–147.
8.
SharafuddinMOlsonCHSunSKresowikTFCorsonJD. Endovascular treatment of celiac and mesenteric arteries stenoses: applications and results. J Vasc Surg. 2003;38(4):692–698.
9.
SharafuddinMJNicholsonRMKresowikTFAminPBHoballahJJSharpWJ. Endovascular recanalization of total occlusions of the mesenteric and celiac arteries. J Vasc Surg. 2012;55(6):1674–1681.
MooreMMcSweeneySFultonGBuckleyJMaherMGuineyM. Reperfusion hemorrhage following superior mesenteric artery stenting. Cardiovasc Intervent Radiol. 2008;31(suppl 2):S57–S61.
12.
San NorbertoEMatín-PedrosaMFlotaCGutiérrezDGarcía-SaizIVaqueroC. Efectos beneficiosos de la prostaglandina E1 en la isquemia-reperfusión intestinal. In: PROCIVAS, ed. Cirugía Endovascular De Las Arterias Viscerales Abdominales. 2016:63–71. ISBN: 978-84-608-4236 -1.
13.
GrootjansJLenaertsKBuurmanWADejongCHDerikxJP. Life and death at the mucosal-luminal interface: new perspectives on human intestinal ischemia-reperfusion. World J Gastroenterol. 2016;22(9):2760–2770.
14.
GonzalezLMMoeserAJBikslagerAT. Animal models of ischemia-reperfusion-induced intestinal injury: progress and promise for translational research. Am J Physiol Gastrointest Liver Physiol. 2015;308(2):G63–G75.
